Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Vesitirim™ in Men Postmarketing Observational Study
A postmarketing observational study of Vesitirim in men has completed, evaluating its effects on lower urinary tract symptoms and overactive…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder [Phase 4]
A Phase 4 study evaluated the efficacy and safety of fesoterodine in vulnerable elderly subjects with overactive bladder; results were poste…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Lessening Incontinence by Learning Yoga [NA]
A completed UCSF trial evaluated whether learning yoga can lessen urinary incontinence symptoms.
-
CLINICAL_TRIALS research · 2013-01-07Clinical Trial Update: Study of Overactive Bladder in Women With Prolapse
This document is a clinical trial update describing a study on overactive bladder in women with pelvic organ prolapse, sponsored by Radboud …
-
CLINICAL_TRIALS trial_result · 2013-01-01Clinical Trial Update: Physical Therapy for Overactive Bladder
A clinical trial evaluating physical therapy for overactive bladder sponsored by National Taiwan University Hospital was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-12-17Clinical Trial Update: Management of the Idiopathic Overactive Bladder With Botulinum Toxin: Systematic Review
This document is a systematic review evaluating the use of botulinum toxin to manage idiopathic overactive bladder.
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Clinical Trial to Study a Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence Overactive Bladder (OAB) [NA]
A completed clinical trial evaluated a non-invasive neurostimulation device for urgency urinary incontinence related to overactive bladder, …
-
FDA approval · 2012-11-30FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for trospium chloride submitted by Glenmark Pharmaceuticals Inc., USA.
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug [NA]
A clinical trial update examining post-treatment normalized urodynamics as the objective gold standard for cure in female patients with over…
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms [NA]
Clinical trial comparing Detrol Long Acting (LA) with Estrace Vaginal Cream for overactive bladder symptoms has completed, with results post…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder [Phase 3]
Phase 3 trial update showing long-term safety and efficacy of the beta-3 agonist mirabegron (YM178) for overactive bladder; results complete…
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder [Phase 3]
Phase 3 trial results for mirabegron (YM178) in adults with overactive bladder; the study completed and results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder [Phase 3]
Phase 3 study evaluating the efficacy and safety of Mirabegron (YM178) for overactive bladder; results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder [Phase 3]
Phase 3 trial evaluating the efficacy and safety of mirabegron for overactive bladder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan [Phase 2]
This update reports the completion of a Phase 2 controlled study of ONO-8025 (KRP-197) for overactive bladder in Japan.
-
FDA approval · 2012-10-12FDA Approved: TROSPIUM CHLORIDE — Original Application (Actavis Pharma, Inc.)
FDA approves Actavis's trospium chloride as a generic for the treatment of overactive bladder.
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan [Phase 3]
A Phase 3 trial in Japan evaluating Ono Pharmaceutical's ONO-8025 (KRP-197) for overactive bladder has completed.
-
FDA approval · 2012-10-10FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's OXYTROL (oxybutynin) supplemental application, enabling a label modification for the product.
-
CLINICAL_TRIALS trial_result · 2012-09-20Clinical Trial Update: Evaluating the Change of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure for Stress Incontinence [Phase 4]
This Phase 4 trial update assesses changes in overactive bladder symptoms in women after a pubovaginal sling procedure for stress urinary in…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms [Phase 4]
A Phase 4 trial evaluating solifenacin for mitigation of ureteral stent–induced pain and lower urinary tract symptoms has completed, with re…
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder [Phase 2]
Phase 2 study evaluating safety and efficacy of DR-3001 versus placebo in women with overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial [Phase 4]
Allergan completed the Phase 4 SMART-II trial of Sanctura (trospium chloride) for overactive bladder, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency [Phase 4]
Phase 4 trial evaluating the efficacy and safety of fesoterodine for symptoms of overactive bladder, including nocturnal urinary urgency; st…
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: The Long-term Efficacy of Electrical Pudendal Nerve Stimulation for the Urgency-Frequency Syndrome in Women
This completed clinical trial from the Shanghai Institute of Acupuncture, Moxibustion and Meridian evaluates the long-term efficacy of elect…
-
FDA label_change · 2012-08-03FDA Approved: VESICARE — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for VESICARE (solifenacin succinate) submitted by Astellas Pharma US, Inc.